Literature DB >> 10939593

Transformation of mortal human fibroblasts and activation of a growth inhibitory pathway by the bovine papillomavirus E5 oncoprotein.

L M Petti1, F A Ray.   

Abstract

The 44-amino acid bovine papillomavirus E5 protein induces tumorigenic transformation of immortal rodent fibroblasts by binding to and activating the platelet-derived growth factor beta receptor (PDGFbetaR). Here E5 was expressed in mortal human diploid fibroblasts (HDFs), which lack the accumulated genetic changes that are present in immortal rodent cells. E5 induced focus formation and morphological transformation of HDFs without inducing anchorage independence or immortalization. Similar effects were observed with the v-sis and neu* oncogenes. E5-PDGFbetaR complexes were observed in the E5-expressing HDFs, as was constitutive PDGFbetaR activation, which was required for the transforming activity of E5. The E5 HDFs attained a higher saturation density than the control cells, expressing increased levels of hyperphosphorylated retinoblastoma protein at subconfluent densities. However, when these cells reached confluence, growth inhibition accompanied by dramatic down-regulation of the PDGFbetaR, and retinoblastoma protein was induced apparently by a factor secreted into the medium. This may represent a novel negative feedback mechanism controlling PDGFbetaR-induced proliferation and thereby protecting against complete transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10939593

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  11 in total

1.  A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor.

Authors:  Lisa M Petti; Kristina Talbert-Slagle; Megan L Hochstrasser; Daniel DiMaio
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

2.  A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome.

Authors:  Cecilie Bredrup; Tomasz Stokowy; Julie McGaughran; Samuel Lee; Dipak Sapkota; Ileana Cristea; Linda Xu; Kåre Steinar Tveit; Gunnar Høvding; Vidar Martin Steen; Eyvind Rødahl; Ove Bruland; Gunnar Houge
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

3.  Accumulation of neoplastic traits prior to spontaneous in vitro transformation of rat cholangiocytes determines susceptibility to activated ErbB-2/Neu.

Authors:  Rebecca A Rozich; David R Mills; Kate E Brilliant; Helen M Callanan; DongQin Yang; Umadevi Tantravahi; Douglas C Hixson
Journal:  Exp Mol Pathol       Date:  2010-07-22       Impact factor: 3.362

4.  Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.

Authors:  Christopher P Mill; Kathleen L Gettinger; David J Riese
Journal:  Exp Cell Res       Date:  2010-11-24       Impact factor: 3.905

Review 5.  The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango.

Authors:  Kristina Talbert-Slagle; Daniel DiMaio
Journal:  Virology       Date:  2008-11-06       Impact factor: 3.616

6.  Multiple transmembrane amino acid requirements suggest a highly specific interaction between the bovine papillomavirus E5 oncoprotein and the platelet-derived growth factor beta receptor.

Authors:  Valerie M Nappi; Lisa M Petti
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  De novo selection of oncogenes.

Authors:  Kelly M Chacón; Lisa M Petti; Elizabeth H Scheideman; Valentina Pirazzoli; Katerina Politi; Daniel DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-16       Impact factor: 11.205

Review 8.  The E5 proteins.

Authors:  Daniel DiMaio; Lisa M Petti
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

Review 9.  Papillomavirus E5: the smallest oncoprotein with many functions.

Authors:  Aldo Venuti; Francesca Paolini; Lubna Nasir; Annunziata Corteggio; Sante Roperto; Maria S Campo; Giuseppe Borzacchiello
Journal:  Mol Cancer       Date:  2011-11-11       Impact factor: 27.401

10.  Inhibition of eIF2alpha dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis.

Authors:  Sharon J Sequeira; Huei Chi Wen; Alvaro Avivar-Valderas; Eduardo F Farias; Julio A Aguirre-Ghiso
Journal:  BMC Cell Biol       Date:  2009-09-15       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.